Stocks · US
COO
XNAS
The Cooper Companies, Inc. Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E18.93x
P/B1.30x
P/S2.55x
EPS$3.00
ROE6.85%
ROA4.50%
Dividend yield0.00%
EV/EBITDA14.20x
Debt/Equity0.31
Free cash flow$678M
Returns and 52-week range
1W-0.35%
1M-18.91%
3M-18.93%
6M-18.99%
1Y-19.91%
YTD-30.43%
52W high$89.83
52W low$51.01
From 52W high-37.18%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Vaxcyte, Inc. Common Stock | $11.0B | — | 3.98 | +9.06% |
| Repligen Corp | $10.7B | 257.46 | 5.06 | +4.33% |
| 이뮤니티바이오 | $11.0B | — | — | +19.93% |
| Avantor, Inc. | $10.7B | — | 1.90 | +3.07% |
| BioMarin Pharmaceuticals Inc | $11.1B | 152.64 | 1.76 | -15.50% |
| 유니버설 헬스 서비시스 | $10.4B | 6.80 | 1.38 | +4.38% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.